Drug Sales in Emerging Markets to Match U.S. by 2016

by Blogburger on July 12, 2012

China, India, Brazil, Russia and 12 other emerging markets will make up almost one-third of global pharmaceutical spending within four years, as newly wealthy people and nations spend more on health care, a report shows. Rising drug spending in 16 emerging pharmaceutical markets will lead the industry’s global sales growth by 2016, according to a report released today by the IMS Institute for Healthcare Informatics, a Parsippany, New Jersey-based research arm of drug sales analysis firm IMS Health Inc. As emerging markets grow, European government budget cuts and drugs losing U.S. patent…

WN.com – Science News

Comments on this entry are closed.

Previous post:

Next post: